8KAM image
Entry Detail
PDB ID:
8KAM
Title:
Crystal structure of SpyCas9 in complex with sgRNA and 16nt target DNA
Biological Source:
PDB Version:
Deposition Date:
2023-08-03
Release Date:
2024-06-05
Method Details:
Experimental Method:
Resolution:
3.91 Å
R-Value Free:
0.29
R-Value Work:
0.26
R-Value Observed:
0.26
Space Group:
C 1 2 1
Macromolecular Entities
Polymer Type:polyribonucleotide
Description:RNA (98-MER)
Chain IDs:A
Chain Length:98
Number of Molecules:1
Biological Source:Streptococcus pyogenes serotype M1
Polymer Type:polypeptide(L)
Description:CRISPR-associated endonuclease Cas9/Csn1
Chain IDs:B
Chain Length:1368
Number of Molecules:1
Biological Source:Streptococcus pyogenes serotype M1
Polymer Type:polydeoxyribonucleotide
Description:DNA (5'-D(*CP*AP*AP*TP*AP*CP*CP*TP*CP*TP*TP*CP*AP*AP*TP*TP*AP*GP*AP*AP*CP*AP*CP*G)-3')
Chain IDs:C
Chain Length:24
Number of Molecules:1
Biological Source:Streptococcus pyogenes serotype M1
Polymer Type:polydeoxyribonucleotide
Description:DNA (5'-D(*TP*TP*TP*AP*GP*GP*TP*AP*TP*TP*G)-3')
Chain IDs:D
Chain Length:11
Number of Molecules:1
Biological Source:Streptococcus pyogenes serotype M1
Primary Citation
Trans-nuclease activity of Cas9 activated by DNA or RNA target binding.
Nat.Biotechnol. 43 558 568 (2025)
PMID: 38811761 DOI: 10.1038/s41587-024-02255-7

Abstact

Type V and type VI CRISPR-Cas systems have been shown to cleave nonspecific single-stranded DNA (ssDNA) or single-stranded RNA (ssRNA) in trans, but this has not been observed in type II CRISPR-Cas systems using single guide RNA. We show here that the type II CRISPR-Cas9 systems directed by CRISPR RNA and trans-activating CRISPR RNA dual RNAs show RuvC domain-dependent trans-cleavage activity for both ssDNA and ssRNA substrates. Cas9 possesses sequence preferences for trans-cleavage substrates, preferring to cleave T- or C-rich ssDNA substrates. We find that the trans-cleavage activity of Cas9 can be activated by target ssDNA, double-stranded DNA and ssRNA. The crystal structure of Cas9 in complex with guide RNA and target RNA provides a structural basis for the binding of target RNA to activate Cas9. Based on the trans-cleavage activity of Cas9 and nucleic acid amplification technology, we develop the nucleic acid detection platforms DNA-activated Cas9 detection and RNA-activated Cas9 detection, which are capable of detecting DNA and RNA samples with high sensitivity and specificity.

Legend

Protein

Chemical

Disease

Primary Citation of related structures